Food And Drug Administration Effect of User Fees on Drug Approval Times, Withdrawals, And Other Agency Activities

In 1992, the Prescription Drug User Fee Act (PDUFA) was enacted to provide additional resources for the FDA to speed up the process of reviewing applications for new drugs & biological products. This report examines: (1) how PDUFA has affected the funding & approval times for FDA's review of new drug & biologic applications, (2) whether PDUFA has had an effect on the funding & oper. of FDA's non-PDUFA activities, (3) whether the workload, attrition, & non-professional development of FDA reviewers have changed since the user fee program was reauthorized in 1997, & (4) how the rate of drug withdrawals from the market has changed since PDUFA was enacted in 1992 & what actions are being taken by FDA to monitor adverse drug effects. Charts & tables.Heinrich, Janet is the author of 'Food And Drug Administration Effect of User Fees on Drug Approval Times, Withdrawals, And Other Agency Activities', published 2002 under ISBN 9780756742898 and ISBN 0756742897.